The American Society of Clinical Oncology (ASCO) released a position statement that raises concerns about home infusion of anticancer therapy and Centers for Medicare & Medicaid Services (CMS) regulations regarding the practice.
July 30, 2020
July 27, 2020
Jonathan W. Friedberg, MD, MMSc, has been appointed as the next editor-in-chief of the Journal of Clinical Oncology (JCO), the flagship journal of the American Society of Clinical Oncology (ASCO).
June 25, 2020
Nancy R. Daly, MS, MPH, has been named Chief Executive Officer of Conquer Cancer, the American Society of Clinical Oncology (ASCO) Foundation, a move that reflects Ms. Daly’s growing leadership of the organization and successful expansion of its research grants and awards program.
May 19, 2020
ASCO released the ASCO Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemic, which provides detailed guidance to oncology practices on the immediate and short-term steps that could be taken to help protect the safety of patients and healthcare staff before resuming more routine care operations during the COVID-19 public health crisis.
April 23, 2020
ASCO today announced the results of a survey that tracked the initial impact of the COVID-19 pandemic on cancer clinical trials, highlighted a new research initiative to address the data gap on the coronavirus’ effect on individuals with cancer, and set forth a road to recovery as the cancer care delivery system prepares for life after COVID-19.
April 10, 2020
ASCO today launched the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) to help the entire cancer community learn about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 infections impact the delivery of cancer care and patient outcomes.
April 9, 2020
The American Society of Clinical Oncology (ASCO) today released a set of recommendations to support the oncology community as health care institutions across the United States face potentially difficult decisions around the allocation of scarce health care resources during the COVID-19 pandemic. In some geographic areas, the ongoing crisis is expected to demand more resources—including ventilators, critical and intensive care beds, and medications—than the U.S. or local health care systems can supply, and institutions will need to develop allocation decision policies as they provide care for a growing number of patients.
February 19, 2020
ASCO released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral medications provided they are maintained within a closed system. The Society also makes recommendations to ensure that these programs are implemented appropriately, with sufficient patient protections in place.
February 4, 2020
The emergence of novel systemic therapies — combined in new and better ways — has significantly changed the role of cancer surgery. In recognition of the substantial progress made in this area in the past year, in Clinical Cancer Advances 2020 — just released today— the American Society of Clinical Oncology (ASCO) has named is the Refinement of Surgical Treatment of Cancer as the Advance of the Year.
December 19, 2019
ASCO applauds Congress for working across party lines to raise the minimum age for purchasing tobacco products to 21 and for continuing its commitment to investing in our nation's biomedical research infrastructure.
December 17, 2019
The American Society of Clinical Oncology (ASCO) has elected Everett E. Vokes, MD, FASCO, a long-time member and volunteer, to serve as its President for the term beginning in June 2021.
November 26, 2019
On November 26, 2019, ASCO released a major update to its Patient-Centered Oncology Payment (PCOP) model, an alternative payment model designed to support transformation in cancer care delivery and reimbursement while ensuring that patients with cancer have access to high-quality, high-value care.
October 30, 2019
A report of findings from the American Society of Clinical Oncology’s third annual National Cancer Opinion Survey.
September 25, 2019
The ASCO award honors Members of Congress who are leading champions for patients and survivors of cancer, their families, and their cancer care teams.
September 24, 2019
Roughly one in five young adults uses e-cigarettes daily or recreationally, and nearly one in four believes the products are harmless and not addictive, according to findings from the American Society of Clinical Oncology (ASCO)’s third annual National Cancer Opinion Survey. This comes after the Centers for Disease Control and Prevention (CDC) issued the results from its National Youth Tobacco Survey earlier this month, reporting that e-cigarette use among pre-teens and teens is on the rise.
Pages |